Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 14, 2025 • 5:00 AM ET

Date/Time Source News Release
07/01/2025 09:00 AM EDT GlobeNewswire Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic
06/25/2025 09:00 AM EDT GlobeNewswire Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control
06/17/2025 09:00 AM EDT GlobeNewswire Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth
06/11/2025 09:00 AM EDT GlobeNewswire Femasys Announces Partnership with Carolinas Fertility Institute, One of America's Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations
05/30/2025 08:00 AM EDT GlobeNewswire Femasys Announces Pricing of Underwritten Public Offering and Concurrent Private Placement with Gross Proceeds of $4.5 Million
05/29/2025 04:23 PM EDT GlobeNewswire Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
05/08/2025 05:01 PM EDT GlobeNewswire Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update
03/27/2025 09:00 AM EDT GlobeNewswire Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update
03/19/2025 09:20 AM EDT GlobeNewswire Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations
03/18/2025 09:00 AM EDT GlobeNewswire Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain
Page

Additional News

As of July 14, 2025 • 5:00 AM ET

Date/Time Source News Release
05/30/2025 01:01 PM EDT PRISM News PRISM Mid-Day Movers: Biopharma Results and Enhanced Coverage for AI Cybersecurity Drive Index Movement
05/30/2025 10:33 AM EDT SeekingAlpha Femasys announces pricing of underwritten public offering and concurrent private placement with gross proceeds of $4.5M
05/29/2025 04:30 PM EDT SeekingAlpha Femasys announces public offering, concurrent private placement
05/09/2025 03:36 AM EDT SeekingAlpha Femasys GAAP EPS of -$0.23
05/08/2025 07:00 PM EDT Zacks Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Femasys Inc.
05/06/2025 09:05 AM EDT Zacks Curis (CRIS) Reports Q1 Loss, Tops Revenue Estimates
05/01/2025 05:15 PM EDT Zacks BioMarin Pharmaceutical (BMRN) Beats Q1 Earnings and Revenue Estimates
04/02/2025 10:46 AM EDT SeekingAlpha Femasys reports FY results
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.